Lamifiban
Lamifiban is a nonpeptide glycoprotein IIb/IIIa receptor and platelet aggregation antagonist. Lamifiban in combination with thrombolytic therapy effectively restores coronary arterial patency. Lamifiban is promising for research of acute coronary syndromes.
For research use only. We do not sell to patients.
- CAS No.: 144412-49-7
- Formula: C24H28N4O6
- Molecular Weight:468.50
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Chemical Information
-
CAS No. 144412-49-7
-
Molecular Weight 468.50
-
Formula C24H28N4O6
-
SMILES
O=C(O)COC1CCN(C([C@@H](NC(C2=CC=C(C(N)=N)C=C2)=O)CC3=CC=C(O)C=C3)=O)CC1
-
Synonyms
Ro 44-9883
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Moliterno DJ, et al. Randomized, Placebo-Controlled Study of Lamifiban with Thrombolytic Therapy for the Treatment of Acute Myocardial Infarction: Rationale and Design for the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) Study. J Thromb Thrombolysis. 1995;2(3):165-169. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)